Omada Health, Inc. (OMDA) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US68170A1088
Omada Health, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 260.21 m USD |
| Gross profit | 170.94 m USD |
| Operating income | -11.97 m USD |
| EBIT | -15.55 m USD |
| Net income | -12.78 m USD |
| Diluted EPS – continuing operations | -0.35 USD |
Full history since 2022, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Omada Health, Inc.
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.
More stocks
- CGN New Energy Holdings Co Ltd (1811.HK)
- EMTEK (Shenzhen) Co. Ltd. (300938.SZ)
- Tokai Carbon Korea Co. Ltd (064760.KQ)
- De Rucci Healthy Sleep Co. Ltd. (001323.SZ)
- Sidea Semiconductor Equipment (Shenzhen) Co., Ltd. (301629.SZ)
- Boozt AB (BOOZT.ST)
- Aedas Homes SA (AEDAS.MC)
- Oil-Dri Corp of America (ODC)
- Beijing Lier High Temperature Materials Co Ltd (002392.SZ)
- Red Violet, Inc. (RDVT)
- Lamda Development SA (LAMDA.AT)
- Taiwan Hon Chuan Enterprise Co Ltd (9939.TW)
Not investment advice. All data without warranty, price as of 05.11.2026. Details in the risk notice.